PD‐L1 plays a critical role in ischemic stroke recovery, with PD‐L1 mAb treatment demonstrating age‐dependent therapeutic efficacy by enhancing BBB integrity, reducing neuroinflammation and apoptosis, and modulating peripheral immune responses. This evidence concerns the gene CD274 and ischemic stroke.